Literature DB >> 12482874

Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.

Yan Xu1, Jean C Clark, Bruce J Aronow, Chitta R Dey, Cong Liu, Jamie L Wooldridge, Jeffrey A Whitsett.   

Abstract

Cystic fibrosis, the most commonly inherited lethal pulmonary disorder in Caucasians, is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). To identify genomic responses to the presence or absence of CFTR in pulmonary tissues in vivo, microarray analyses of lung mRNAs were performed on whole lung tissue from mice lacking (CFTR(-)) or expressing mouse CFTR (CFTR(+)). Whereas the histology of lungs from CFTR(-) and CFTR(+) mice was indistinguishable, statistically significant increases in the relative abundance of 29 and decreases in 25 RNAs were identified by RNA microarray analysis. Of RNAs whose expression was consistently altered by the absence of CFTR, functional classes of genes influencing gene transcription, inflammation, intracellular trafficking, signal transduction, and ion transport were identified. RNAs encoding the transcription factor CCAAT enhancer-binding protein (CEBP) delta and interleukin (IL) 1beta, both known to regulate CFTR expression, were induced, perhaps indicating adaptation to the lack of CFTR. RNAs mediating lung inflammation including calgranulin-S100 family members, IL-1beta and IL-4, were increased. Likewise, expression of several membrane transport proteins that interact directly with CFTR were increased, suggesting that CFTR-protein complexes initiate genomic responses. Absence of CFTR influenced the expression of genes modulating diverse pulmonary cell functions that may ameliorate or contribute to the pathogenesis of CF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482874     DOI: 10.1074/jbc.M210277200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.

Authors:  Christian Mueller; Sofia A Braag; Allison Keeler; Craig Hodges; Mitchell Drumm; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

Review 3.  Genetic variation and clinical heterogeneity in cystic fibrosis.

Authors:  Mitchell L Drumm; Assem G Ziady; Pamela B Davis
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

4.  AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites.

Authors:  Lark Kyun Kim; Rimpei Morita; Yasushi Kobayashi; Stephanie C Eisenbarth; Chun Geun Lee; Jack Elias; Elizabeth E Eynon; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

5.  Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.

Authors:  Matthew J DiMagno; Sae-Hong Lee; Chung Owyang; Shi-yi Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

6.  β-arrestin-2 regulation of the cAMP response element binding protein.

Authors:  Mary E Manson; Deborah A Corey; Sharon M Rymut; Thomas J Kelley
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

7.  Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity.

Authors:  Karen S Raraigh; Sangwoo T Han; Emily Davis; Taylor A Evans; Matthew J Pellicore; Allison F McCague; Anya T Joynt; Zhongzhou Lu; Melis Atalar; Neeraj Sharma; Molly B Sheridan; Patrick R Sosnay; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

Review 8.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

9.  Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

Authors:  Troy D Pashuck; Sarah E Franz; Molly K Altman; Clive H Wasserfall; Mark A Atkinson; Thomas J Wronski; Terence R Flotte; Michael S Stalvey
Journal:  Pediatr Res       Date:  2009-03       Impact factor: 3.756

10.  High-content functional screen to identify proteins that correct F508del-CFTR function.

Authors:  Agata M Trzcinska-Daneluti; Diane Ly; Lise Huynh; Chong Jiang; Christopher Fladd; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2008-12-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.